ES2058473T3 - Analogos de tuftsina y vacunas que contienen estos como coadyuvantes. - Google Patents

Analogos de tuftsina y vacunas que contienen estos como coadyuvantes.

Info

Publication number
ES2058473T3
ES2058473T3 ES89201371T ES89201371T ES2058473T3 ES 2058473 T3 ES2058473 T3 ES 2058473T3 ES 89201371 T ES89201371 T ES 89201371T ES 89201371 T ES89201371 T ES 89201371T ES 2058473 T3 ES2058473 T3 ES 2058473T3
Authority
ES
Spain
Prior art keywords
vaccines
tuftsina
coadjuvants
analogs
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89201371T
Other languages
English (en)
Inventor
Luciano Nencioni
Piero Pileri
Samuele Peppoloni
Sergio Silvestri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sclavo SpA
Original Assignee
Sclavo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo SpA filed Critical Sclavo SpA
Application granted granted Critical
Publication of ES2058473T3 publication Critical patent/ES2058473T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EL INVENTO TIENE QUE VER CON EL USO DE UN COMPUESTO ANALOGO A LA TUFTSINA DE FORMULA (I) O DE UNA SAL ACIDA O BASICA, ACEPTABLE FARMACEUTICAMENTE, COMO COADYUGANTE PARA POTENCIAR, EN UN ORGANISMO VIVO, LA RESPUESTA DE UN ANTICUERPO CONTRA SUS ANTIGENOS NATURALES O SINTETICOS, ASI COMO CON LAS NUEVAS COMPOSICIONES PARA VACUNAS, QUE COMPRENDEN UNO O MAS ANTIGENOS, JUNTO CON UNA CANTIDAD COADYUGANTE DEL COMPUESTO DE FORMULA (I) O DE UNA DE LAS SALES.
ES89201371T 1989-02-10 1989-05-30 Analogos de tuftsina y vacunas que contienen estos como coadyuvantes. Expired - Lifetime ES2058473T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919408A IT1230712B (it) 1989-02-10 1989-02-10 Composizione per vaccini

Publications (1)

Publication Number Publication Date
ES2058473T3 true ES2058473T3 (es) 1994-11-01

Family

ID=11157520

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89201371T Expired - Lifetime ES2058473T3 (es) 1989-02-10 1989-05-30 Analogos de tuftsina y vacunas que contienen estos como coadyuvantes.

Country Status (8)

Country Link
US (1) US4957736A (es)
EP (1) EP0392095B1 (es)
JP (1) JPH02215797A (es)
AT (1) ATE110739T1 (es)
CA (1) CA1338318C (es)
DE (1) DE68917907T2 (es)
ES (1) ES2058473T3 (es)
IT (1) IT1230712B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US5741680A (en) * 1996-09-03 1998-04-21 Cera Products, Inc. Buffer composition base and method of formulation for oral vaccine delivery

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
US4390528A (en) * 1981-11-16 1983-06-28 Research Corporation Tuftsinyl-tuftsin
EP0253190B1 (en) * 1986-07-16 1992-12-30 ENIRICERCHE S.p.A. Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPH02215797A (ja) 1990-08-28
IT8919408A0 (it) 1989-02-10
EP0392095B1 (en) 1994-08-31
EP0392095A2 (en) 1990-10-17
ATE110739T1 (de) 1994-09-15
US4957736A (en) 1990-09-18
CA1338318C (en) 1996-05-07
EP0392095A3 (en) 1991-01-30
IT1230712B (it) 1991-10-29
DE68917907T2 (de) 1995-01-05
DE68917907D1 (de) 1994-10-06

Similar Documents

Publication Publication Date Title
AR002043A1 (es) Utilizacion de agonistas de alfa (1l) para el tratamiento de la incontinencia urinaria.
BR0313101A (pt) Novos lipopeptìdeos imunogênicos que compreendem epitopos de linfócitos t-helper e linfócitos t citotóxicos (ctl), e métodos para sua produção e uso
AR009742A1 (es) Aminoacidos modificados, medicamentos que contienen estos compuestos y procedimiento para su preparacion
ES2077948T3 (es) Preparacion para el cuidado externo de la piel.
UY27740A1 (es) Nuevos compuestos
ES2195034T3 (es) Inhibidor de metaloproteinasas, composicion farmaceutica que contiene este inhibidor y su utilizacion farmaceutica, y procedimientos que sirven para su preparacion.
CL2008003788A1 (es) Composicion farmaceutico que comprende a) el anticuerpo b-ly1 humanizado (anti-cd20/antigeno de referenciacion restringida del linfocito b humano/bp35, de tipo ii), b) opcionalmente de 0,001% al 1%p/v de por lo menos un surfactante, y c) de 1 a 100 mm de un tampon; uso para tratar enfermedades relacionadas con cd20.
HN2002000319A (es) Benzamida, heteroarilamida y amidas inversas
CY1118334T1 (el) Χρηση δαπτομυκινης
BR0313154A (pt) Novos lipopeptìdeos imunogênicos que compreendem epitopos de célula t-helper e de célula b
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
ES2051800T3 (es) Tableta cubierta de dihidropiridina.
AR024060A1 (es) Nuevos compuestos farmaceuticamente activos
AR046970A1 (es) Esteres de fosfato de florfenicol
UY27329A1 (es) Champues con alcohol de behenilo
UY27586A1 (es) Cis- imidaxolinas
MX9306220A (es) Ptp 1d: una proteina tirosina fosfatasa novedosa.
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
CO2022014867A2 (es) Composiciones farmacéuticas y productos farmacéuticos de interleucina–15 humana heterodimérica (hetil–15)
BRPI0808599A2 (pt) "ácido nucléico, vacina, composição farmacêutica, uso de um ácido nucléico e método para estimular uma imunoresposta versus um epítopo das células t"
PA8532001A1 (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos
ES2032640T3 (es) Productos conservados para el tratamiento del cabello y el cuerpo, asi como utilizacion de una combinacion de sustancias conservantes.
AR013462A1 (es) Nuevos peptidomimeticos para el tratamiento de trastornos oseos, metodos para su produccion y drogas que contienen estos compuestos
MX9303123A (es) Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen.
ES2182489T3 (es) Sales de calcio de antibioticos lipopeptidicos, procedimiento para su preparacion y utilizacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 392095

Country of ref document: ES